PMID- 31242396 OWN - NLM STAT- MEDLINE DCOM- 20200106 LR - 20200106 IS - 1480-3275 (Electronic) IS - 0008-4166 (Linking) VI - 65 IP - 11 DP - 2019 Nov TI - Continuing surveillance of invasive Haemophilus influenzae disease in northwestern Ontario emphasizes the importance of serotype a and non-typeable strains as causes of serious disease: a Canadian Immunization Research Network (CIRN) Study. PG - 805-813 LID - 10.1139/cjm-2019-0210 [doi] AB - In the post-Haemophilus influenzae serotype b (Hib) vaccine era, invasive H. influenzae serotype a (Hia) disease emerged in Canadian First Nation, Inuit, and Alaskan Indigenous populations. Previous studies by our group found a high incidence of invasive Hia disease in northwestern Ontario. We retrospectively reviewed 24 cases (4 pediatric and 20 adult) of invasive H. influenzae disease hospitalized at the northwestern Ontario regional hospital between August 2011 and June 2018. The objectives were to further document the changing epidemiology of invasive H. influenzae disease in the region and to discuss potential control measures. Twenty-two H. influenzae isolates were serotyped and characterized using molecular-biological methods. Of the serotyped cases, there were 2 Hib, 9 Hia, and 11 non-typeable (NTHi). All Hia isolates belonged to the most common sequence types (ST) found in Canada (ST-23 and ST-929); 8 out of 9 were pan susceptible to antibiotics. One (11%) of 9 Hia and 5 (45%) of 11 NTHi cases were fatal. Our data on the consistent presence of serious invasive H. influenzae disease, with 41% prevalence of Hia (9 out of 22 serotyped isolates) and 50% prevalence of NTHi strains (11 out of 22), emphasize the importance of continued surveillance of H. influenzae in the post-Hib vaccine era and are critical information to inform potential vaccine development. FAU - Cerqueira, Ashley AU - Cerqueira A AD - Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada. FAU - Byce, Sarah AU - Byce S AD - Faculty of Medicine, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada. FAU - Tsang, Raymond S W AU - Tsang RSW AD - Vaccine Preventable Bacterial Diseases, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada. FAU - Jamieson, Frances B AU - Jamieson FB AD - Public Health Laboratories, Public Health Ontario, Toronto, Ontario, Canada. AD - Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. FAU - Kus, Julianne V AU - Kus JV AD - Public Health Laboratories, Public Health Ontario, Toronto, Ontario, Canada. AD - Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. FAU - Ulanova, Marina AU - Ulanova M AD - Division of Medical Sciences, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada. LA - eng PT - Journal Article DEP - 20190626 PL - Canada TA - Can J Microbiol JT - Canadian journal of microbiology JID - 0372707 RN - 0 (Haemophilus Vaccines) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Child, Preschool MH - Epidemiological Monitoring MH - Haemophilus Infections/epidemiology/immunology/*microbiology/prevention & control MH - Haemophilus Vaccines/*administration & dosage/immunology MH - Haemophilus influenzae/classification/genetics/immunology/*isolation & purification MH - Humans MH - Incidence MH - Infant MH - Middle Aged MH - Ontario/epidemiology MH - Retrospective Studies MH - Serogroup MH - Vaccination MH - Young Adult OTO - NOTNLM OT - Haemophilus influenzae OT - antibiotic susceptibility OT - infection OT - sensibilite aux antibiotiques OT - serotype OT - serotype EDAT- 2019/06/27 06:00 MHDA- 2020/01/07 06:00 CRDT- 2019/06/27 06:00 PHST- 2019/06/27 06:00 [pubmed] PHST- 2020/01/07 06:00 [medline] PHST- 2019/06/27 06:00 [entrez] AID - 10.1139/cjm-2019-0210 [doi] PST - ppublish SO - Can J Microbiol. 2019 Nov;65(11):805-813. doi: 10.1139/cjm-2019-0210. Epub 2019 Jun 26.